Blueprint Medicines (BPMC)
(Delayed Data from NSDQ)
$90.73 USD
-1.53 (-1.66%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $90.87 +0.14 (0.15%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: BMO |
3/2024 | $-1.64 | 16.92% |
Earnings Summary
For their last quarter, Blueprint Medicines (BPMC) reported earnings of -$1.82 per share, beating the Zacks Consensus Estimate of $-2.04 per share. This reflects a positive earnings surprise of 10.78%. Look out for BPMC's next earnings release on May 02, 2024. For the next earning release, we expect the company to report earnings of -$1.64 per share, reflecting a year-over-year increase of 23.72%.
Earnings History
Price & Consensus
Zacks News for BPMC
CRISPR Therapeutics (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?
BPMC: What are Zacks experts saying now?
Zacks Private Portfolio Services